✨ Free AI Report
Beta Bionics, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Beta Bionics, Inc.
Company Research

Beta Bionics, Inc.: Business Overview, Financials & Competitive Analysis

Beta Bionics is a commercial-stage medical device company that designs, develops, and commercializes solutions to enhance the health and quality of life of insulin-requiring people with diabetes. The company offers th...

Analyst-debate audio for Beta Bionics, Inc.

AskCyborg analysts argue the bull and bear cases for Beta Bionics, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
6/ 10Solid

Cyborg Score thesis

High-growth medical device company with strong market adoption in insulin pumps, but profitability remains distant and recent...

Read the full analyst-debate transcript →
Industry Medical Devices - Diabetes Management & Insulin Delivery Systems
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Beta Bionics, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Beta Bionics, Inc. Overview

Pro stress-test →

Beta Bionics is a commercial-stage medical device company that designs, develops, and commercializes solutions to enhance the health and quality of life of insulin-requiring people with diabetes. The company offers the iLet Bionic Pancreas, an insulin delivery device for treating type 1 diabetes in adults and children six years of age and older.

Strategic Profile

Pro stress-test →

Beta Bionics has established itself as a key leader in the durable insulin pump market, as evidenced by sales force productivity, pharmacy channel coverage, and gross margin profile. The company achieved 54% net sales growth in 2025 to $100.3M and more than doubled its installed user base, while guiding 2026 revenue to $130–$135M.

Competitive Landscape

Pro stress-test →

Competitors in the insulin pump and diabetes management space include Tandem Diabetes Care and other durable medical equipment manufacturers. Beta Bionics differentiates through its automated bionic pancreas technology and expanding multi-channel reimbursement strategy, positioning it as an emerging leader in the growing insulin pump market.

Industry Context

Beta Bionics, Inc. operates in Medical Devices - Diabetes Management & Insulin Delivery Systems.

Key facts

Headquarters: Irvine, United States · Revenue: $100.3M (2025) · Market cap: $1.34B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Beta Bionics, Inc..

  • Pharmacy Benefit Plan (PBP) channel sales surged 295% YoY in Q4 2025, demonstrating successful expansion of distribution channels beyond traditional DME with high-30s percentage of Q4 patient starts reimbursed through pharmacy.
  • Installed customer base reached 35,011 users in Q4 2025, up 129% YoY, indicating rapid market penetration and product acceptance.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Reported Q4 2025 revenue of $32.1M (+57% YoY) and full-year 2025 revenue of $100.3M (+54%); guided 2026 revenue to $130–$135M
  • January 2026Analyst coverage initiated with mixed ratings; Lake Street raised price target to $40, while TD Cowen initiated Hold recommendation
  • +1 moreTrack every material event for Beta Bionics, Inc. as it happens. Explore monitoring →
Get alerted when Beta Bionics, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

t:slim X2 with Control-IQInsulin pump with automated glucose control system→Medtronic 780GHybrid closed-loop insulin pump system→Omnipod 5Tubeless automated insulin pump→

Compare Beta Bionics, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Beta Bionics, Inc. operates in Medical Devices - Diabetes Management & Insulin Delivery Systems. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices - Diabetes Management & Insulin Delivery Systems research →
NEW · MCP server

Ask your AI assistant about Beta Bionics, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Beta Bionics, Inc. and its top competitor on Cyborg Score”
“What did Beta Bionics, Inc. do this quarter?”
“Is Beta Bionics, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Beta Bionics, Inc. do?+
Beta Bionics is a commercial-stage medical device company that designs, develops, and commercializes solutions to enhance the health and quality of life of insulin-requiring people with diabetes. The company offers th...
What is Beta Bionics, Inc.'s Cyborg Score?+
Beta Bionics, Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Beta Bionics, Inc.'s main competitors?+
Named competitors include t:slim X2 with Control-IQ, Medtronic 780G, Omnipod 5. The full competitive landscape is in the AskCyborg report.
How can I get the full Beta Bionics, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Beta Bionics, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Beta Bionics, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.